Under the agreement, Cellares will use its Cell Shuttle and Cell Q systems to automate TSC-101 manufacturing processes.
Quality by design is critical for cell and gene therapy manufacturing where process controls directly influence product ...
Researchers from the Critical Analytics for Manufacturing Personalized Medicine (CAMP), an interdisciplinary research group (IRG) of Singapore-MIT Alliance for Research and Technology (SMART), in ...
CDMO and multimodal biosafety testing organization, today announced the enhancement of its dedicated GMP cell banking suites ...
Realize safe, scalable, and compliant cell therapies by building analytical strategies that exceed regulatory expectations.
Critical Resources Ltd (ASX:CRR, FRA:9S70) has advanced its solid-state lithium-ion battery evaluation program into ...
Elegen and Nutcracker Therapeutics launched a pilot program to demonstrate what they label the industry’s first fully synthetic, cell-free manufacturing platform for RNA-based personalized cancer ...
Controlling the entire cell therapy production process—from material receipt to product release—is “essential,” according to AstraZeneca, which says its new $300 million manufacturing facility will be ...
According to the report’s authors, LECO is now used in the production of around one-quarter of TOPCon cells. Image: Trina Solar. A new study has found that the laser-enhanced contact optimisation ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results